CD56+ hematologic malignancies.
Loughran
T P
TP
H. Lee Moffitt Cancer Center and Research Institute, The Veterans Administration Hospital, Tampa, FL 33612, USA.
D019002:CD56 Antigen / Q000032:analysis*; D002454:Cell Differentiation; D019070:Cell Lineage; D020031:Epstein-Barr Virus Infections / Q000453:epidemiology; D005006:Ethnicity; D006801:Humans; D016130:Immunophenotyping; D020407:Internet; D007694:Killer Cells, Natural / Q000737:chemistry / Q000473:pathology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology* / Q000821:virology; D015458:Leukemia, T-Cell / Q000175:diagnosis / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000737:chemistry / Q000473:pathology*; D011379:Prognosis; D012042:Registries
D019002:CD56 Antigen